Follow
Roland Bingisser
Roland Bingisser
Professor, Chair Emergency Department, University of Basel
Verified email at usb.ch - Homepage
Title
Cited by
Cited by
Year
Early diagnosis of myocardial infarction with sensitive cardiac troponin assays
T Reichlin, W Hochholzer, S Bassetti, S Steuer, C Stelzig, S Hartwiger, ...
New England Journal of Medicine 361 (9), 858-867, 2009
21952009
Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial
M Christ-Crain, D Jaccard-Stolz, R Bingisser, MM Gencay, PR Huber, ...
The Lancet 363 (9409), 600-607, 2004
17242004
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial
M Christ-Crain, D Stolz, R Bingisser, C Muller, D Miedinger, PR Huber, ...
American journal of respiratory and critical care medicine 174 (1), 84-93, 2006
13592006
Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial
P Schuetz, M Christ-Crain, R Thomann, C Falconnier, M Wolbers, ...
Jama 302 (10), 1059-1066, 2009
12692009
Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy
D Stolz, M Christ-Crain, R Bingisser, J Leuppi, D Miedinger, C Müller, ...
Chest 131 (1), 9-19, 2007
8582007
Modern triage in the emergency department
M Christ, F Grossmann, D Winter, R Bingisser, E Platz
Deutsches Ärzteblatt International 107 (50), 892, 2010
7462010
Incremental value of copeptin for rapid rule out of acute myocardial infarction
T Reichlin, W Hochholzer, C Stelzig, K Laule, H Freidank, ...
Journal of the American College of Cardiology 54 (1), 60-68, 2009
6482009
Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway
RM Bingisser, PA Tilbrook, PG Holt, UR Kees
The Journal of Immunology 160 (12), 5729-5734, 1998
6451998
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia
B Müller, S Harbarth, D Stolz, R Bingisser, C Mueller, J Leuppi, ...
BMC infectious diseases 7, 1-10, 2007
6322007
Short-term vs conventional glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease: the REDUCE randomized clinical trial
JD Leuppi, P Schuetz, R Bingisser, M Bodmer, M Briel, T Drescher, ...
Jama 309 (21), 2223-2231, 2013
5612013
Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD
D Stolz, M Christ-Crain, NG Morgenthaler, J Leuppi, D Miedinger, ...
Chest 131 (4), 1058-1067, 2007
4602007
Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial
CA Blum, N Nigro, M Briel, P Schuetz, E Ullmer, I Suter-Widmer, ...
The Lancet 385 (9977), 1511-1518, 2015
4502015
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]
M Christ-Crain, NG Morgenthaler, D Stolz, C Müller, R Bingisser, ...
Critical Care 10, 1-8, 2006
3712006
Copeptin: a novel, independent prognostic marker in patients with ischemic stroke
M Katan, F Fluri, NG Morgenthaler, P Schuetz, C Zweifel, R Bingisser, ...
Annals of neurology: official journal of the American Neurological …, 2009
3352009
Circulating levels of copeptin, a novel biomarker, in lower respiratory tract infections
B Müller, N Morgenthaler, D Stolz, P Schuetz, C Müller, R Bingisser, ...
European journal of clinical investigation 37 (2), 145-152, 2007
3092007
Prospective validation of a 1-hour algorithm to rule-out and rule-in acute myocardial infarction using a high-sensitivity cardiac troponin T assay
T Reichlin, R Twerenbold, K Wildi, MR Gimenez, N Bergsma, P Haaf, ...
Cmaj 187 (8), E243-E252, 2015
2642015
Impact of physical activity on cardiovascular risk factors in IDDM
R Lehmann, V Kaplan, R Bingisser, KE Bloch, GA Spinas
Diabetes care 20 (10), 1603-1611, 1997
2511997
Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD
D Stolz, T Breidthardt, M Christ-Crain, R Bingisser, D Miedinger, J Leuppi, ...
Chest 133 (5), 1088-1094, 2008
2352008
The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department
CH Nickel, R Bingisser, NG Morgenthaler
BMC medicine 10, 1-6, 2012
2332012
At risk of undertriage? Testing the performance and accuracy of the emergency severity index in older emergency department patients
FF Grossmann, T Zumbrunn, A Frauchiger, K Delport, R Bingisser, ...
Annals of emergency medicine 60 (3), 317-325. e3, 2012
2242012
The system can't perform the operation now. Try again later.
Articles 1–20